Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
Absci Corp
A biotech company that uses artificial intelligence and synthetic biology to design antibodies and other proteins for new medicines. Founded in 2012 by Sean McClain in Vancouver, Washington, the name "Absci" is short for "antibody science." Its platform pairs generative AI with high-throughput lab testing to help drugmakers develop biologic therapies, and it went public through a SPAC merger in 2021.
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
8.01 Other Events
1.01 Entry into a Material Definitive Agreement · 8.01 Other Events · 9.01 Financial Statements and Exhibits
5.07 Submission of Matters to a Vote of Security Holders
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits
1.01 Entry into a Material Definitive Agreement · 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits
8.01 Other Events · 9.01 Financial Statements and Exhibits